Kara B. Duffy

1.3k total citations
17 papers, 1.1k citations indexed

About

Kara B. Duffy is a scholar working on Molecular Biology, Physiology and Pharmacology. According to data from OpenAlex, Kara B. Duffy has authored 17 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Physiology and 3 papers in Pharmacology. Recurrent topics in Kara B. Duffy's work include Phosphodiesterase function and regulation (5 papers), Neuroscience and Neuropharmacology Research (3 papers) and Cholinesterase and Neurodegenerative Diseases (3 papers). Kara B. Duffy is often cited by papers focused on Phosphodiesterase function and regulation (5 papers), Neuroscience and Neuropharmacology Research (3 papers) and Cholinesterase and Neurodegenerative Diseases (3 papers). Kara B. Duffy collaborates with scholars based in United States and Canada. Kara B. Duffy's co-authors include Nigel H. Greig, Harold W. Holloway, TracyAnn Perry, Edward L. Spangler, Bryan D. Devan, Mark P. Mattson, Donald K. Ingram, Jonna L. Bowker, Peter R. Mouton and Julie A. Mattison and has published in prestigious journals such as Clinical Cancer Research, Endocrinology and Neuroscience.

In The Last Decade

Kara B. Duffy

17 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kara B. Duffy United States 12 382 339 258 257 158 17 1.1k
Hiranya Pintana Thailand 19 439 1.1× 488 1.4× 470 1.8× 238 0.9× 95 0.6× 47 1.5k
Mei Qiu China 15 246 0.6× 227 0.7× 230 0.9× 153 0.6× 74 0.5× 63 935
Gerard D. Schellenberg United States 5 259 0.7× 536 1.6× 215 0.8× 196 0.8× 89 0.6× 6 1.0k
Lucy M. Hinder United States 22 474 1.2× 797 2.4× 204 0.8× 201 0.8× 117 0.7× 32 1.6k
Paulo W. Pires United States 20 371 1.0× 353 1.0× 313 1.2× 169 0.7× 84 0.5× 46 1.6k
Dana M. Niedowicz United States 16 427 1.1× 578 1.7× 229 0.9× 119 0.5× 115 0.7× 26 1.3k
Benedek Erdős United States 18 237 0.6× 473 1.4× 112 0.4× 160 0.6× 49 0.3× 44 1.1k
Catrina Sims‐Robinson United States 17 399 1.0× 502 1.5× 125 0.5× 202 0.8× 70 0.4× 24 1.2k
Benjamin M. Terry United States 5 432 1.1× 839 2.5× 300 1.2× 263 1.0× 173 1.1× 8 1.4k
Teresa Montiel Mexico 24 658 1.7× 701 2.1× 233 0.9× 554 2.2× 76 0.5× 51 1.7k

Countries citing papers authored by Kara B. Duffy

Since Specialization
Citations

This map shows the geographic impact of Kara B. Duffy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kara B. Duffy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kara B. Duffy more than expected).

Fields of papers citing papers by Kara B. Duffy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kara B. Duffy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kara B. Duffy. The network helps show where Kara B. Duffy may publish in the future.

Co-authorship network of co-authors of Kara B. Duffy

This figure shows the co-authorship network connecting the top 25 collaborators of Kara B. Duffy. A scholar is included among the top collaborators of Kara B. Duffy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kara B. Duffy. Kara B. Duffy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Duffy, Kara B., Balmiki Ray, Debomoy K. Lahiri, et al.. (2019). Effects of Reducing Norepinephrine Levels via DSP4 Treatment on Amyloid-β Pathology in Female Rhesus Macaques (Macaca Mulatta). Journal of Alzheimer s Disease. 68(1). 115–126. 10 indexed citations
2.
Ottinger, Mary Ann, Emma T. Lavoie, Anna E. Tschiffely, et al.. (2018). Embryonic effects of an environmentally relevant PCB mixture in the domestic chicken. Environmental Toxicology and Chemistry. 37(10). 2513–2522. 2 indexed citations
3.
Kabadi, Shruti V., Bogdan A. Stoica, Danna B. Zimmer, et al.. (2015). S100B Inhibition Reduces Behavioral and Pathologic Changes in Experimental Traumatic Brain Injury. Journal of Cerebral Blood Flow & Metabolism. 35(12). 2010–2020. 44 indexed citations
4.
Devan, Bryan D., et al.. (2014). Phosphodiesterase inhibition facilitates cognitive restoration in rodent models of age-related memory decline. Neurorehabilitation. 34(1). 101–111. 28 indexed citations
5.
Li, Yazhou, Kara B. Duffy, Mary Ann Ottinger, et al.. (2010). GLP-1 Receptor Stimulation Reduces Amyloid-β Peptide Accumulation and Cytotoxicity in Cellular and Animal Models of Alzheimer's Disease. Journal of Alzheimer s Disease. 19(4). 1205–1219. 281 indexed citations
6.
Duffy, Kara B., Edward L. Spangler, Bryan D. Devan, et al.. (2007). A blueberry-enriched diet provides cellular protection against oxidative stress and reduces a kainate-induced learning impairment in rats. Neurobiology of Aging. 29(11). 1680–1689. 95 indexed citations
7.
Pistell, Paul J., Kara B. Duffy, Jonna L. Bowker, et al.. (2007). Combined administration of subthreshold doses of the nitric oxide inhibitor, nitro-L-arginine, and muscarinic receptor antagonist, scopolamine, impairs complex maze learning in rats. Behavioural Pharmacology. 18(8). 801–805. 7 indexed citations
8.
Devan, Bryan D., Paul J. Pistell, Kara B. Duffy, et al.. (2007). Sildenafil citrate attenuates a complex maze impairment induced by intracerebroventricular infusion of the NOS inhibitor Nω-nitro-L-arginine methyl ester. European Journal of Pharmacology. 563(1-3). 134–140. 33 indexed citations
9.
Martin, Bronwen, Michele L. Pearson, Erin Golden, et al.. (2007). Sex-Dependent Metabolic, Neuroendocrine, and Cognitive Responses to Dietary Energy Restriction and Excess. Endocrinology. 148(9). 4318–4333. 153 indexed citations
10.
Perry, TracyAnn, Harold W. Holloway, Ananda Weerasuriya, et al.. (2006). Evidence of GLP-1-mediated neuroprotection in an animal model of pyridoxine-induced peripheral sensory neuropathy. Experimental Neurology. 203(2). 293–301. 168 indexed citations
11.
Lee, Garrick D., Dan L. Longo, Yue Wang, et al.. (2006). Transient Improvement in Cognitive Function and Synaptic Plasticity in Rats Following Cancer Chemotherapy. Clinical Cancer Research. 12(1). 198–205. 74 indexed citations
12.
Devan, Bryan D., Jonna L. Bowker, Kara B. Duffy, et al.. (2005). Phosphodiesterase inhibition by sildenafil citrate attenuates a maze learning impairment in rats induced by nitric oxide synthase inhibition. Psychopharmacology. 183(4). 439–445. 70 indexed citations
13.
Devan, Bryan D., Kara B. Duffy, Jonna L. Bowker, et al.. (2005). Phosphodiesterase type 5 (PDE5) inhibition and cognitive enhancement. Drugs of the Future. 30(7). 725–725. 9 indexed citations
14.
15.
Cunningham, Steven C., Kara B. Duffy, Bryan D. Devan, et al.. (2004). The cholinesterase inhibitor, phenserine, improves Morris water maze performance of scopolamine-treated rats. Life Sciences. 76(10). 1073–1081. 27 indexed citations
16.
Devan, Bryan D., Marcel Jiménez, Jonna L. Bowker, et al.. (2004). Phosphodiesterase inhibition by sildenafil citrate attenuates the learning impairment induced by blockade of cholinergic muscarinic receptors in rats. Pharmacology Biochemistry and Behavior. 79(4). 691–699. 76 indexed citations
17.
Duffy, Kara B.. (2003). Physician Assistants: Filling the Gap in Patient Care in Academic Hospitals. The Journal of Physician Assistant Education. 14(3). 158–167. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hiranya Pintana Breakdown of academic impact, for papers by Mei Qiu Breakdown of academic impact, for papers by Gerard D. Schellenberg Breakdown of academic impact, for papers by Lucy M. Hinder Breakdown of academic impact, for papers by Paulo W. Pires Breakdown of academic impact, for papers by Dana M. Niedowicz Breakdown of academic impact, for papers by Benedek Erdős Breakdown of academic impact, for papers by Catrina Sims‐Robinson Breakdown of academic impact, for papers by Benjamin M. Terry Breakdown of academic impact, for papers by Teresa Montiel
Rankless by CCL
2026